This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The study "Impact of Chronic Cough on Quality of Life," by French et al¹ in the August 10/24, 1998, issue of the ARCHIVES is a welcome addition to a growing trend of taking into consideration things that bother people and not just things that might kill them anytime soon. The chief complaint (eg, cough) is paramount to the patient; but after serious causes have been eliminated, too many physicians lose interest and forget to treat the symptom adequately, as the authors note. Obviously, specific diseases should be treated specifically whenever possible, but what about those few (but not rare) patients who continue to hack after treatment, or the lingering cough after a viral upper respiratory tract infection (other causes having been excluded)? They want a simple cough suppressant, which brings me to the main point of this letter.

Whatever happened to "ETH and C"(elixir terpin hydrate with codeine, aka, "GI . . . [Full Text of this Article]